How might we incentivize the pharmaceutical industry to develop new drugs for the developing world?
Health, Nutrition, and Population
Low cost production methods for essential drugs and vaccines, preferably within the region or in-country. Development of vaccines that will not require cold storage.
How might we bring to market a portable, low cost means of sterilizing medical instruments and related surgical facilities?
Food security with main emphasis to food safety and zoonotic diseases control need to be a priority. No food security, no truly democratic society and no development. Zoonotic foodborne diseases are wih no boundaries and major problems globally.
How might we improve ARV adherence?
How might we strengthen the ability of women to protect themselves from infection with HIV?
How might we prevent the transmission of malaria through a long-acting method?
How might we increase the effectiveness of vasectomy?
How might we scale up the use of Uniject with DepoProvera (for family planning), oxytocin (for postpartum hemorrhage) and gentamicin (for newborn sepsis) quickly, safely and sustainably?
How can we build capacity in mental health programs?
Development of direct partnerships and collaborative projects between universities, academic institutions and organizations in developing countries and developed countries. Collaboration within regions as well. Sustainability must be considered in the plan.
How might we encourage open source mechanisms for drug discovery?